Loading quotes...
Core data
| Name | Kelly CRISPR & Gene Editing Technology ETF |
| Issuer | iShares |
| Fund domicile | Canada |
| TER | 0.52% |
| Fund size | €13.89m |
| P/E ratio | 17.46 |
| P/B ratio | 3.93 |
| Inception date | 26/04/2022 |
| Website |
Composition
| Holdings | Share |
|---|---|
| 12.80% | |
| 6.83% | |
| 6.26% | |
| 3.79% | |
| 3.63% | |
| 3.51% | |
| 3.49% | |
| 3.48% | |
| 3.42% | |
| 3.30% |
As of 29/10/2026
Top sectors
| Sector | Share |
|---|---|
Health Care | 94.10% |
Materials | 1.10% |
Top countries
| Country | Share |
|---|---|
USA | 69.32% |
France | 5.69% |
Japan | 5.28% |
Switzerland | 4.53% |
Denmark | 4.43% |
Germany | 3.47% |
United Kingdom | 2.78% |
Canada | 2.52% |
China | 1.73% |
South Korea | 0.26% |
